{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:52:20Z","timestamp":1792108340473,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Endometriosis is a common, chronic gynecological disease that affects women\u2019s fertility potential. Dydrogesterone is an effective and safe drug that is under-utilized due to limited clinical research. The purpose of this evidence mapping is to identify, describe, and analyze the current available evidence regarding dydrogesterone for the treatment of endometriosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>We performed a search in electronic databases: Medline, The Cochrane Library, EMBASE, PubMed, CNKI, Wanfang, VIP, and CBM. We also hand-searched google for relevant studies. Our primary outcomes included changes in pain relief including pelvic pain, dysmenorrhea, and dyspareunia. Secondary outcomes included pregnancy rate, frequency of analgesic use, and other reported outcomes according to specific settings in the studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 377 references screened, 19 studies were included in the data synthesis involving 1709 female participants. Nearly three-quarters were either randomized control trials or clinical control trials. Compared with gestrinone, dydrogesterone relieved dysmenorrhea, increased the pregnancy rate, and reduced the risk of certain adverse events. Compared with GnRH-a, dydrogesterone also lowered the risk of endometriosis recurrence and elevated transaminase levels. Whether there was any difference in efficacy between dydrogesterone and leuprolide acetate, letrozole or traditional Chinese medicine remains unclear due to insufficient data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The amount and quality of evidence evaluating the effects of dydrogesterone for the treatment of endometriosis is generally very low. Limited evidence suggests that dydrogesterone may have some advantages over gestrinone, GnRH agonists, and other therapeutic interventions in treating endometriosis. However, this conclusion should be interpreted with caution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-020-05900-z","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T12:03:07Z","timestamp":1609761787000},"page":"231-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Dydrogesterone in the treatment of endometriosis: evidence mapping and meta-analysis"],"prefix":"10.1007","volume":"304","author":[{"given":"Chao","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7945-7166","authenticated-orcid":false,"given":"Yingfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"3","key":"5900_CR1","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/humrep\/det457","volume":"29","author":"GAJ Dunselman","year":"2014","unstructured":"Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D\u2019Hooghe T, Bie BD et al (2014) ESHRE guideline: management of women with endometriosis. Hum Reprod 29(3):400\u2013412","journal-title":"Hum Reprod"},{"issue":"1","key":"5900_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.fertnstert.2008.04.056","volume":"92","author":"C Meuleman","year":"2009","unstructured":"Meuleman C, Vandenabeele B, Fieuws S, Spiessens C, Timmerman D, D\u2019Hooghe T (2009) High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril 92(1):68\u201374","journal-title":"Fertil Steril"},{"key":"5900_CR3","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/aje\/kwh275","volume":"160","author":"SA Missmer","year":"2004","unstructured":"Missmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Marshall LM, Hunter DJ (2004) Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 160:784\u2013796","journal-title":"Am J Epidemiol"},{"issue":"1","key":"5900_CR4","first-page":"68","volume":"111","author":"VL La Rosa","year":"2020","unstructured":"La Rosa VL, De Franciscis P, Barra F, Schiattarella A, T\u00f6r\u00f6k P, Shah M, Karaman E, Marques Cerentini T, Di Guardo F, Gullo G, Ponta M, Ferrero S (2020) Quality of life in women with endometriosis: a narrative overview. Minerva Med 111(1):68\u201378","journal-title":"Minerva Med"},{"issue":"1","key":"5900_CR5","first-page":"79","volume":"111","author":"VL La Rosa","year":"2020","unstructured":"La Rosa VL, De Franciscis P, Barra F, Schiattarella A, Tropea A, Tesarik J, Shah M, Kahramanoglu I, Marques Cerentini T, Ponta M, Ferrero S (2020) Sexuality in women with endometriosis: a critical narrative review. Minerva Med 111(1):79\u201389","journal-title":"Minerva Med"},{"issue":"22","key":"5900_CR6","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.3390\/ijms20225615","volume":"20","author":"AS Lagan\u00e0","year":"2019","unstructured":"Lagan\u00e0 AS, Garzon S, G\u00f6tte M, Vigan\u00f2 P, Franchi M, Ghezzi F, Martin DC (2019) The pathogenesis of endometriosis: molecular and cell biology insights. Int J Mol Sci 20(22):5615","journal-title":"Int J Mol Sci"},{"key":"5900_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.mehy.2017.03.032","volume":"103","author":"AS Lagan\u00e0","year":"2017","unstructured":"Lagan\u00e0 AS, Vitale SG, Salmeri FM, Triolo O, Ban Frange\u017e H, Vrta\u010dnik-Bokal E, Stojanovska L, Apostolopoulo V, Granese R, Sofo V (2017) Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses 103:10\u201320","journal-title":"Med Hypotheses"},{"key":"5900_CR8","first-page":"795976","volume":"2015","author":"SH Ahn","year":"2015","unstructured":"Ahn SH, Monsanto SP, Miller C, Singh SS, Thomas R, Tayade C (2015) Pathophysiology and immune dysfunction in endometriosis. Biomed Res Int 2015:795976","journal-title":"Biomed Res Int"},{"key":"5900_CR9","doi-asserted-by":"publisher","first-page":"7924021","DOI":"10.1155\/2018\/7924021","volume":"2018","author":"SG Vitale","year":"2018","unstructured":"Vitale SG, Capriglione S, Peterlunger I, La Rosa VL, Vitagliano A, Noventa M, Valenti G, Sapia F, Angioli R, Lopez S, Sarpietro G, Rossetti D, Zito G (2018) The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxidative Med Cell Longev 2018:7924021","journal-title":"Oxidative Med Cell Longev"},{"key":"5900_CR10","unstructured":"National Institute for Health and Care Excellence (2017) Endometriosis: diagnosis and management. UK."},{"issue":"3","key":"5900_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.fertnstert.2012.05.031","volume":"98","author":"American Society for Reproductive Medicine","year":"2012","unstructured":"American Society for Reproductive Medicine (2012) Endometriosis and infertility: a committee opinion. Fertil Steril 98(3):591\u2013598","journal-title":"Fertil Steril"},{"issue":"7","key":"5900_CR12","first-page":"772","volume":"28","author":"H Liu","year":"2019","unstructured":"Liu H, Dai Y, Huo Y, Zhao J, Sun X, Bai Y et al (2019) Application of modified version of Chinese medicine clinical pathway for dysmenorrhea in staging treatment of endometriosis-associated infertility. J Reprod Med 28(7):772\u2013776","journal-title":"J Reprod Med"},{"issue":"2","key":"5900_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.rbmo.2018.11.017","volume":"38","author":"G Griesinger","year":"2019","unstructured":"Griesinger G, Tournaye H, Macklon N, Petraglia F, Arck P, Blockeel C et al (2019) Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction. Reprod Biomed Online 38(2):249\u2013259","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"5900_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.steroids.2011.02.043","volume":"76","author":"TL Ri\u017ener","year":"2011","unstructured":"Ri\u017ener TL, Bro\u017ei\u010d P, Doucette C, Turek-Etienne T, Muller-Vieira U, Sonneveld E et al (2011) Selectivity and potency of the retroprogesterone dydrogesterone in vitro. Steroids 76(6):607\u2013615","journal-title":"Steroids"},{"issue":"3","key":"5900_CR15","first-page":"138","volume":"37","author":"PJ Taylor","year":"1992","unstructured":"Taylor PJ, Kredentser JV (1992) Nonsurgical management of minimal and moderate endometriosis to enhance fertility. Int J Fertil 37(3):138\u2013143","journal-title":"Int J Fertil"},{"issue":"1","key":"5900_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1471-0528.1976.tb00734.x","volume":"83","author":"WIH Johnston","year":"1976","unstructured":"Johnston WIH (1976) Dydrogesterone and endometriosis. Br J Obstetr Gynaecol 83(1):77\u201380","journal-title":"Br J Obstetr Gynaecol"},{"key":"5900_CR17","first-page":"1704","volume":"7","author":"H Tagreed","year":"2018","unstructured":"Tagreed H, Mohanad M, Hayder F (2018) Comparison of the efficacy and safety between dienogest and dydrogesterone in treatment of endometriosis: prospective study. Int J Sci Res 7:1704\u20131707","journal-title":"Int J Sci Res"},{"issue":"3","key":"5900_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.10.007","volume":"18","author":"CJ Creutzfeldt","year":"2009","unstructured":"Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, Becker KJ, McPharlin TO, Tirschwell DL (2009) Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage. J Stroke Cerebrovasc Dis 18(3):221\u2013228","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"5900_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0028-2243(87)90008-6","volume":"26","author":"FJ Cornillie","year":"1987","unstructured":"Cornillie FJ, Puttemans P, Brosens IA (1987) Histology and ultrastucture of human endometriotic tissues treated with dydrogesterone (Duphaston). Eur J Obstet Gynecol Reprod Biol 26(1):39\u201355","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"5900_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0015-0282(16)56991-X","volume":"62","author":"CE Overton","year":"1994","unstructured":"Overton CE, Lindsay PC, Johal B, Collins SA, Siddle NC, Shaw RW et al (1994) A randomized, double-blind, placebo-controlled study of luteal phase dydrogesterone (Duphaston*) in women with minimal to mild endometriosis. Fertil Steril 62(4):701\u2013707","journal-title":"Fertil Steril"},{"issue":"SUPPL. 1","key":"5900_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/09513590701669583","volume":"23","author":"P Trivedi","year":"2007","unstructured":"Trivedi P, Selvaraj K, Mahapatra PD, Srivastava S, Malik S (2007) Effective post-laparoscopic treatment of endometriosis with dydrogesterone. Gynecol Endocrinol 23(SUPPL. 1):73\u201376","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"5900_CR22","first-page":"513","volume":"11","author":"Y Feng","year":"2016","unstructured":"Feng Y (2016) Clinical effect of progesterone in patients received endometriosis surgery and influence on pregnancy outcome. J Minim Invasive Med 11(4):513\u2013515","journal-title":"J Minim Invasive Med"},{"issue":"3","key":"5900_CR23","first-page":"53","volume":"28","author":"Y Ji","year":"2015","unstructured":"Ji Y (2015) Observation on the clinical effect of Duphaston in treating 60 cases of endometriosis. Med Inf 28(3):53\u201354","journal-title":"Med Inf"},{"issue":"5","key":"5900_CR24","first-page":"146","volume":"23","author":"S Li","year":"2016","unstructured":"Li S (2016) Application effect comparison of dydrogesterone and gestrinone in ovarian endometriosis patients after conservative surgery. China Mod Med 23(5):146\u2013148","journal-title":"China Mod Med"},{"issue":"3","key":"5900_CR25","first-page":"269","volume":"31","author":"X Li","year":"2015","unstructured":"Li X, He C, Wu D, Wu F (2015) Therapeutic effects of dydrogesterone and gestrenene on endometriosis after operation. Clin Med China 31(3):269\u2013272","journal-title":"Clin Med China"},{"issue":"6","key":"5900_CR26","first-page":"43","volume":"6","author":"Y Li","year":"2019","unstructured":"Li Y (2019) Clinical observation of 90 cases of endometriosis treated with Duphaston. J Pract Gynecol Endocrinol 6(6):43\u201349","journal-title":"J Pract Gynecol Endocrinol"},{"issue":"18","key":"5900_CR27","first-page":"160","volume":"23","author":"J Liu","year":"2017","unstructured":"Liu J (2017) The postoperative comparative study of digesterone and gestrinone for ovarian endometriosis. Contemp Med 23(18):160\u2013161","journal-title":"Contemp Med"},{"issue":"1","key":"5900_CR28","first-page":"197","volume":"31","author":"J Liu","year":"2016","unstructured":"Liu J (2016) Clinical observation of dydrogesterone and gestrinone after surgical treatment of endometriosis. Matern Child Health Care China 31(1):197\u2013199","journal-title":"Matern Child Health Care China"},{"issue":"3","key":"5900_CR29","first-page":"402","volume":"46","author":"Y Luo","year":"2017","unstructured":"Luo Y (2017) The effect of dydrogesterone on serum CA 125 in patients with endometriosis. Shanxi Med J 46(3):402\u2013404","journal-title":"Shanxi Med J"},{"issue":"23","key":"5900_CR30","first-page":"54","volume":"27","author":"Y Wang","year":"2018","unstructured":"Wang Y, Huang J (2018) Effect of dydrogesterone treatment on serum CA125 in patients with endometriosis. J Med Aesthet Cosmetol 27(23):54","journal-title":"J Med Aesthet Cosmetol"},{"issue":"3","key":"5900_CR31","first-page":"468","volume":"19","author":"Z Xie","year":"2019","unstructured":"Xie Z, Yang B, Qian L (2019) Postoperative effect of didroxyprogesterone tablets in patients with endometriosis and related factor levels. Chin Rem Clin 19(3):468\u2013470","journal-title":"Chin Rem Clin"},{"issue":"2","key":"5900_CR32","first-page":"93","volume":"19","author":"L Zhang","year":"2013","unstructured":"Zhang L, Liu W (2013) Therapeutic effects of two types of progestogen on endometriosis after laparoscopic operation. Chin J Healthy Birth Child Care 19(2):93\u201395","journal-title":"Chin J Healthy Birth Child Care"},{"issue":"3","key":"5900_CR33","first-page":"1001","volume":"11","author":"MR Orazov","year":"2019","unstructured":"Orazov MR, Radzinsky VY, Khamoshina MB, Kostin IN, Toktar LR, Kavteladze EV et al (2019) The efficacy of combined management of endometriosis-associated infertility. Int J Pharm Res 11(3):1001\u20131006","journal-title":"Int J Pharm Res"},{"key":"5900_CR34","first-page":"S40","volume":"2","author":"SM Walker","year":"1982","unstructured":"Walker SM (1982) The treatment of endometriosis with dydrogesterone. Br J Clin Pract 2:S40-46","journal-title":"Br J Clin Pract"},{"issue":"4","key":"5900_CR35","first-page":"42","volume":"42","author":"GM Makhmudova","year":"2003","unstructured":"Makhmudova GM, Nazhmutdinova DK, Gafarova D, Lukmanova I (2003) Efektivnost na lechenieto s duphaston na zheni prekarali rekonstruktivno-plastichni operatsii pri endometrioza [Efficacy of duphaston treatment in women with endometriosis after reconstructive surgery]. Akusherstvo i ginekologiia 42(4):42\u201346","journal-title":"Akusherstvo i ginekologiia"},{"issue":"3","key":"5900_CR36","first-page":"002122","volume":"14","author":"J Brown","year":"2012","unstructured":"Brown J, Kives S, Akhtar M (2012) Progestagens and anti-progestagens for pain associated with endometriosis (Review). Cochrane Database Syst Rev 14(3):002122","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"5900_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3109\/09513598709082692","volume":"1","author":"S Telimaa","year":"1987","unstructured":"Telimaa S, Puolakka J, Ronnberg L, Kauppila A (1987) Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol 1(1):13\u201323","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"5900_CR38","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/S0015-0282(16)60364-3","volume":"50","author":"S Telimaa","year":"1988","unstructured":"Telimaa S (1988) Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis. Fertil Steril 50(6):872\u2013875","journal-title":"Fertil Steril"},{"issue":"8","key":"5900_CR39","first-page":"S42","volume":"32","author":"P Devroey","year":"2003","unstructured":"Devroey P (2003) Ovarian stimulation regimens in women with endometriosis. J Gynecol Obstet Biol Reprod 32(8):S42\u2013S44","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"5900_CR40","doi-asserted-by":"publisher","first-page":"3617179","DOI":"10.1155\/2016\/3617179","volume":"2016","author":"AS Lagan\u00e0","year":"2016","unstructured":"Lagan\u00e0 AS, Vitale SG, Trovato MA, Palmara VL, Rapisarda AM, Granese R, Sturlese E, De Dominici R, Alecci S, Padula F, Chiofalo B, Grasso R, Cignini P, D\u2019Amico P, Triolo O (2016) Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int 2016:3617179","journal-title":"Biomed Res Int"},{"key":"5900_CR41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ejogrb.2018.10.057","volume":"231","author":"R Raffaelli","year":"2018","unstructured":"Raffaelli R, Garzon S, Baggio S, Genna M, Pomini P, Lagan\u00e0 AS, Ghezzi F, Franchi M (2018) Mesenteric vascular and nerve sparing surgery in laparoscopic segmental intestinal resection for deep infiltrating endometriosis. Eur J Obstet Gynecol Reprod Biol 231:214\u2013219","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05900-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05900-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05900-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T11:04:34Z","timestamp":1622286274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05900-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["5900"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05900-z","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}